SPMs & Inflammation Resolution | HormoneSynergy®

Inflammation is a normal part of immune defense, healing, and tissue repair. It is supposed to begin when needed and then move through an organized resolution process as the original threat or injury is brought under control.

That resolution phase has become an important area of research because inflammation does not simply disappear when pro-inflammatory signaling declines. The body produces lipid mediators that help coordinate the transition toward cleanup, repair, and a return to tissue balance. Specialized pro-resolving mediators, commonly called SPMs, are part of that biology.

Dr. Kathryn Retzler has used SPM-focused nutritional support for years and continues to consider it one of the more useful supplement categories in longevity practice. The science, however, is more specific than the name “SPM supplement” sometimes suggests, and the human evidence is strongest in a few defined areas rather than across every condition associated with inflammation.

One-Minute Read

Specialized pro-resolving mediators are lipid signaling molecules involved in the active resolution phase of inflammation. They include families such as resolvins, protectins, maresins, and lipoxins. Commercial marine lipid supplements commonly described as “SPM” products generally do not contain large quantities of these downstream mediators themselves. Instead, they are typically standardized to upstream omega-3-derived compounds such as 18-HEPE, 17-HDHA, and 14-HDHA, which participate in pro-resolving pathways.

This distinction is worth understanding because the clinical research has largely studied marine lipid concentrates enriched in these compounds rather than purified resolvins or maresins. Small human studies have reported improvements in pain and some measures of quality of life, including a randomized placebo-controlled pilot trial in people with symptomatic knee osteoarthritis. Other human research has shown that supplementation can increase circulating pro-resolving pathway intermediates and, in some settings, selected downstream mediators.

The evidence is promising, but it is not broad enough to claim that these supplements prevent cardiovascular disease, protect the brain, slow biological aging, or treat chronic inflammatory disease. At HormoneSynergy®, we use them more narrowly: as targeted nutritional support when joint comfort, physical recovery, or inflammation-resolution biology is relevant to the person in front of us.

Inflammation and Resolution Are Different Parts of the Same Process

Inflammation is often discussed as though it is inherently harmful. In reality, an inflammatory response is necessary for fighting infection, responding to injury, clearing damaged tissue, and initiating repair.

The problem arises when inflammatory signaling persists longer than necessary or when the normal transition toward resolution is impaired. Research into chronic low-grade inflammation and inflammaging has helped draw attention to this distinction.

Resolution is not simply the absence of inflammation. It is an active biological process involving changes in immune-cell behavior, clearance of damaged cells and debris, and lipid signaling that helps tissues move back toward homeostasis.

What Specialized Pro-Resolving Mediators Actually Are

SPMs are a family of naturally produced lipid signaling molecules involved in inflammation resolution. They include resolvins, protectins, maresins, and lipoxins. Several are produced through metabolic pathways involving the omega-3 fatty acids EPA and DHA, while lipoxins arise primarily from arachidonic acid pathways.

The compounds most often seen on commercial SPM-enriched marine lipid products are 18-hydroxyeicosapentaenoic acid (18-HEPE), 17-hydroxydocosahexaenoic acid (17-HDHA), and 14-hydroxydocosahexaenoic acid (14-HDHA).

These compounds are better described as pro-resolving pathway intermediates or precursors. For example, 18-HEPE participates in pathways leading toward E-series resolvins, while 17-HDHA is associated with pathways leading toward D-series resolvins and protectins. 14-HDHA is involved in pathways associated with maresin formation.

The supplement category is commonly called “SPM,” and we continue to use that familiar terminology. From a biochemical standpoint, however, it is more accurate to say that many of these products provide a marine lipid concentrate standardized to compounds involved in SPM biosynthesis rather than a large dose of purified downstream SPM molecules.

What RetzlerRx® Synergy SPM Provides

RetzlerRx® Synergy SPM is our private-label version of the same underlying formulation used in Metagenics SPM Active. Each two-softgel serving provides 1 gram of active fractionated marine lipid concentrate standardized to 18-HEPE, 17-HDHA, and 14-HDHA.

The marine lipid concentrate is derived from anchovy, sardine, and mackerel. We use the product as targeted nutritional support rather than as a general replacement for omega-3 supplementation or as a treatment for inflammatory disease.

What Human Studies Have Found

The human literature is still relatively small, but it has moved beyond purely laboratory and animal research.

A 2020 study evaluated a fractionated marine lipid concentrate standardized to 17-HDHA and 18-HEPE in adults with chronic pain. Participants reported improvements in several measures of pain and quality of life over four weeks. The study was uncontrolled, which means the findings cannot establish that the supplement itself caused those improvements, but it provided an early signal that justified more rigorous trials.

A subsequent randomized, double-blind, placebo-controlled pilot study, known as the GAUDI study, evaluated an SPM-enriched marine oil in adults with symptomatic knee osteoarthritis. In the per-protocol analysis of 51 participants, pain scores were significantly lower in the supplementation group than in the placebo group after eight and twelve weeks. Intermittent pain also improved at twelve weeks.

The results were not uniformly positive. WOMAC functional scores were not significantly different between groups, and several secondary outcomes showed trends rather than statistically significant differences. This was also a relatively small pilot trial, so it should be viewed as encouraging rather than definitive evidence.

Another human study in adults with obesity found that an enriched marine oil containing 18-HEPE, 17-HDHA, and 14-HDHA increased several circulating hydroxy fatty acids and was accompanied by increases in selected downstream mediators, including resolvin E1 and a DPA-derived maresin. The study did not show increases in D-series resolvins and did not establish a clinical treatment effect.

Omega-3s and Pro-Resolving Pathways

EPA and DHA remain important nutritional fatty acids in their own right. They also provide substrates from which the body can generate pro-resolving lipid mediators.

A 2026 meta-analysis of 11 randomized trials involving 810 participants found that omega-3 supplementation significantly increased circulating 18-HEPE and 17-HDHA. The authors appropriately noted that higher concentrations of these precursors do not automatically mean that downstream SPM production increases or that a particular clinical outcome will improve.

This is one reason we do not view an SPM-enriched marine lipid concentrate as a replacement for a well-formulated omega-3 supplement. The two products may overlap biologically, but they are used for different nutritional purposes.

For more on omega-3s and broader supplement selection, see The Practical Longevity Supplement Stack: What We Use and Why.

Where the Evidence Is Still Limited

SPM biology is being studied in cardiovascular disease, metabolic dysfunction, neurological disease, immune regulation, tissue repair, and other areas related to aging. Much of that work is mechanistic, observational, or preclinical.

At this point, human supplementation trials do not justify claims that an oral SPM-enriched marine lipid supplement stabilizes atherosclerotic plaque, prevents cognitive decline, slows biological aging, treats neuroinflammation, or reduces cardiovascular events. Those questions remain research questions.

This is an important distinction because an interesting biological pathway is not the same thing as a demonstrated clinical outcome. At HormoneSynergy®, we prefer to keep the claim proportional to the evidence.

Why Dr. Retzler Still Uses SPM Support

Despite the limitations of the current research, this remains a supplement category Dr. Kathryn Retzler may use because the underlying resolution biology is well established and the early human clinical evidence is relevant to common concerns such as joint discomfort and physical recovery.

The decision is individualized. Someone with good mobility, little physical discomfort, an omega-3-rich diet, and no particular recovery concerns may have little reason to add another marine lipid supplement. Someone dealing with persistent joint discomfort, high physical training demands, or a clinical situation in which recovery is a priority may have a more compelling reason to consider it.

This is consistent with the larger HormoneSynergy® approach to supplements. We do not build programs around the number of capsules someone can take. Nutrition, exercise, sleep, muscle, metabolic health, cardiovascular risk, hormone status, and appropriate medical care remain far more important to healthspan. Supplements are used where they add something useful to that foundation.

Frequently Asked Questions

Are 18-HEPE, 17-HDHA, and 14-HDHA themselves SPMs?

They are commonly grouped with SPM ingredients on commercial labels, but more precise scientific terminology describes them as hydroxylated omega-3 metabolites and intermediates or precursors in pro-resolving pathways. Downstream SPMs include compounds such as resolvins, protectins, and maresins.

Is an SPM supplement the same as fish oil?

No. Conventional fish oil primarily provides EPA and DHA. SPM-enriched marine lipid concentrates are fractionated and standardized to compounds such as 18-HEPE, 17-HDHA, and 14-HDHA. They may be used alongside omega-3 supplementation when appropriate.

What does the human evidence support most strongly?

The most relevant clinical evidence currently involves pain, joint discomfort, quality of life, and changes in circulating pro-resolving lipid mediators. The studies are still relatively small, and the results should not be generalized to every disease associated with inflammation.

Does Synergy SPM treat chronic inflammation?

No. Synergy SPM is a dietary supplement and is not intended to diagnose, treat, cure, or prevent inflammatory disease. It may be used as nutritional support for normal inflammation-resolution and recovery pathways.*

What is in RetzlerRx® Synergy SPM?

Each two-softgel serving provides 1 gram of active fractionated marine lipid concentrate standardized to 18-HEPE, 17-HDHA, and 14-HDHA. The marine lipid concentrate is derived from anchovy, sardine, and mackerel.

Selected Research

Callan N, et al. Early evidence of efficacy for orally administered SPM-enriched marine lipid fraction on quality of life and pain in a sample of adults with chronic pain. Journal of Translational Medicine. 2020;18:401.

Félix-Soriano E, et al. Randomized, double-blind, placebo-controlled study to evaluate the effect of treatment with an SPMs-enriched oil on chronic pain and inflammation, functionality, and quality of life in patients with symptomatic knee osteoarthritis: GAUDI study. Journal of Translational Medicine. 2023.

Pal A, et al. Enriched marine oil supplement increases specific plasma specialized pro-resolving mediators in adults with obesity. The American Journal of Clinical Nutrition. 2022.

2026 meta-analysis. Omega-3 fatty acids, specialized pro-resolving mediators, and depression: a mechanistic meta-analysis of precursors and clinical implications. The analysis included 11 randomized trials and evaluated changes in circulating 18-HEPE and 17-HDHA after omega-3 supplementation.

Educational Note

*These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes and is not intended to diagnose, treat, cure, or prevent disease. Nutritional supplements should be selected in the context of diet, medications, medical history, allergies, and individual health needs. Synergy SPM contains fish.